India's Neuland Laboratories up as FDA ends inspection with zero observations
** Shares of pharmaceutical firm Neuland Laboratories
NEUL.NS rise as much as 6.8% to 6,463.95 rupees
** Co says U.S. Food and Drug Administration completed
inspection at its Hyderabad facility with zero observations
** NEUL last up 5.7%, set for highest weekly gains in March
if trend holds
** NEUL trading above 50-, 100- day simple moving averages
(Reporting by Anisha Ajith in Bengaluru)
((anisha.ajith@thomsonreuters.com))
Recent news on Neuland Laboratories
See all newsIndia's Neuland Laboratories jumps after approving $13.3 mln land purchase for expansion
Brief: Neuland Laboratories Approves Capital Expenditure Of 1.26 Billion Rupees For Land Purchase In Kakinada
Brief: Neuland Laboratories Says US FDA Inspects Neuland Laboratories Unit 3 From August 10 To 14, 2026
Brief: Neuland Laboratories June-Quarter Consol Profit 1.48 Billion Rupees
Brief: Neuland Laboratories March-Quarter Consol Profit 2.13 Bln Rupees